Современные препараты «искусственной слезы» в лечении больных с синдромом «сухого глаза»
Владимир Всеволодович Бржеский · Meditsinskiy sovet = Medical Council · 2013
Recently, the interest of national ophthalmologists to drug therapy of dry eye syndrome has been growing. In proportion to the growing relevance of the issue, there has been an increase in incidence of dry eye syndrome (DES) and expansion in the range of artificial tears which are the basis for therapy of patients with DES [1, 2, 6].
Cited by 0 works.